AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

被引：909

作者：

Zhang, Bei B. ^{[1
]}

Zhou, Gaochao ^{[1
]}

Li, Cai ^{[1
]}

机构：

[1] Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA

来源：

CELL METABOLISM | 2009年 / 9卷 / 05期

关键词：

ACTIVATED-PROTEIN-KINASE; FATTY-ACID OXIDATION; IMPROVES GLUCOSE-METABOLISM; HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; LIPID-METABOLISM; GENE-EXPRESSION; FOOD-INTAKE; FED RATS; MECHANISM;

D O I：

10.1016/j.cmet.2009.03.012

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) is a key player in regulating energy metabolism, placing it at the center stage in studies of diabetes and related metabolic diseases. Expressed in key metabolically relevant organs, AMPK is activated in response to a variety of stimuli, including cellular stress, exercise, and a wide range of hormones and agents that exert impacts on cellular metabolism. Genetic and pharmacological studies demonstrate that AMPK is required for maintaining glucose homeostasis. Activation of AMPK by pharmacological agents presents a unique challenge, given the complexity of the biology, but holds a considerable potential to reverse the metabolic abnormalities associated with type 2 diabetes.

引用

页码：407 / 416

页数：10

共 82 条

[1] Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the γ2-subunit of AMP-Activated protein kinase [J].

Akman, Hasan O. ;

Sampayo, James N. ;

Ross, Fiona A. ;

Scott, John W. ;

Wilson, Gregory ;

Benson, Lee ;

Bruno, Claudio ;

Shanske, Sara ;

Hardie, D. Grahame ;

Dimauro, Salvatore .

PEDIATRIC RESEARCH, 2007, 62 (04) :499-504

[2] Liver adenosine monophosphate-activated kinase-α2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin [J].

Andreelli, F ;

Foretz, M ;

Knauf, C ;

Cani, PD ;

Perrin, C ;

Iglesias, MA ;

Pillot, B ;

Bado, A ;

Tronche, F ;

Mithieux, G ;

Vaulont, S ;

Burcelin, R ;

Viollet, B .

ENDOCRINOLOGY, 2006, 147 (05) :2432-2441

[3] AMP-activated protein kinase in the heart - Role during health and disease [J].

Arad, Michael ;

Seidman, Christine E. ;

Seidman, J. G. .

CIRCULATION RESEARCH, 2007, 100 (04) :474-488

[4] AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats [J].

Assifi, MM ;

Suchankova, G ;

Constant, S ;

Prentki, M ;

Saha, AK ;

Ruderman, NB .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 289 (05) :E794-E800

[5] Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats [J].

Bergeron, R ;

Previs, SF ;

Cline, GW ;

Perret, P ;

Russell, RR ;

Young, LH ;

Shulman, GI .

DIABETES, 2001, 50 (05) :1076-1082

[6] Predominant α2/β2/γ3 AMPK activation during exercise in human skeletal muscle [J].

Birk, J. B. ;

Wojtaszewski, J. F. P. .

JOURNAL OF PHYSIOLOGY-LONDON, 2006, 577 (03) :1021-1032

[7]

CANTO C, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE07813

[8] Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase [J].

Carey, Andrew L. ;

Steinberg, Gregory R. ;

Macaulay, S. Lance ;

Thomas, Walter G. ;

Holmes, Anna G. ;

Ramm, Georg ;

Prelovsek, Oja ;

Hohnen-Behrens, Cordula ;

Watt, Matthew J. ;

James, David E. ;

Kemp, Bruce E. ;

Pedersen, Bente K. ;

Febbraio, Mark A. .

DIABETES, 2006, 55 (10) :2688-2697

[9] AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons [J].

Claret, Marc ;

Smith, Mark A. ;

Batterham, Rachel L. ;

Selman, Colin ;

Choudhury, Agharul I. ;

Fryer, Lee G. D. ;

Clements, Melanie ;

Al-Qassab, Hind ;

Heffron, Helen ;

Xu, Allison W. ;

Speakman, John R. ;

Barsh, Gregory S. ;

Viollet, Benoit ;

Vaulont, Sophie ;

Ashford, Michael L. J. ;

Carling, David ;

Withers, Dominic J. .

JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (08) :2325-2336

[10] Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase [J].

Collins, Qu Fan ;

Liu, Hui-Yu ;

Pi, Jingbo ;

Liu, Zhenqi ;

Quon, Michael J. ;

Cao, Wenhong .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (41) :30143-30149

← 1 2 3 4 5 6 7 8 9 →